SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $280,211 | -33.3% | 150,000 | -40.0% | 0.00% | – |
| Q3 2022 | $420,000 | +32.9% | 250,000 | 0.0% | 0.00% | – |
| Q2 2022 | $316,000 | -3.7% | 250,000 | 0.0% | 0.00% | – |
| Q1 2022 | $328,000 | -10.4% | 250,000 | 0.0% | 0.00% | – |
| Q4 2021 | $366,000 | -1.6% | 250,000 | 0.0% | 0.00% | – |
| Q3 2021 | $372,000 | +12.0% | 250,000 | 0.0% | 0.00% | – |
| Q2 2021 | $332,000 | +1.5% | 250,000 | 0.0% | 0.00% | – |
| Q1 2021 | $327,000 | -46.4% | 250,000 | 0.0% | 0.00% | – |
| Q4 2020 | $610,000 | +18.0% | 250,000 | 0.0% | 0.00% | – |
| Q3 2020 | $517,000 | -10.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2020 | $575,000 | +55.0% | 250,000 | 0.0% | 0.00% | – |
| Q1 2020 | $371,000 | -23.7% | 250,000 | 0.0% | 0.00% | – |
| Q4 2019 | $486,000 | +47.3% | 250,000 | 0.0% | 0.00% | – |
| Q3 2019 | $330,000 | -56.9% | 250,000 | -28.6% | 0.00% | – |
| Q2 2019 | $766,000 | +23.2% | 350,000 | 0.0% | 0.00% | – |
| Q1 2019 | $622,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 61,662,000 | $127,669,000 | 4.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 94,165,000 | $195,054,000 | 1.73% |
| SSI INVESTMENT MANAGEMENT LLC | 6,418,000 | $13,306,000 | 1.15% |
| Opti Capital Management, LP | 3,625,000 | $7,517,000 | 0.92% |
| LINDEN ADVISORS LP | 32,702,000 | $67,675,000 | 0.82% |
| Verition Fund Management LLC | 14,948,000 | $31,032,000 | 0.62% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 11,418,000 | $23,673,000 | 0.52% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $10,382,000 | 0.40% |
| AQR Arbitrage LLC | 4,625,000 | $9,602,000 | 0.35% |
| Calamos Advisors LLC | 25,051,000 | $51,955,000 | 0.33% |